Facebook Linkedin RSS Twitter Youtube
Home 2022

Rheumatic diseases (Musculoskeletal diseases)

Potential Therapeutic Target for Rheumatoid Arthritis Uncovered
Drug Discovery

Potential Therapeutic Target for Rheumatoid Arthritis Uncovered

Key Protein Identified that Helps Drive Rheumatoid Arthritis Damage
Drug Discovery

Key Protein Identified that Helps Drive Rheumatoid Arthritis Damage

Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio
Drug Discovery

Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

Pathway That Drives Inflammation in Autoimmune Diseases Uncovered
News

Pathway That Drives Inflammation in Autoimmune Diseases Uncovered

Specific ATP Type Critical to Inflammatory Spread in Rheumatoid Arthritis
Drug Discovery

Specific ATP Type Critical to Inflammatory Spread in Rheumatoid Arthritis

Single-Cell RNA-Seq Reveals Immune Cell Genetic Profiles in Autoimmunity
News

Single-Cell RNA-Seq Reveals Immune Cell Genetic Profiles in Autoimmunity

Researchers Uncover Link between Gut Microbiome and Inflammatory Diseases
News

Researchers Uncover Link between Gut Microbiome and Inflammatory Diseases

Rheumatoid Arthritis Prediction Improved by New Biomarkers
News

Rheumatoid Arthritis Prediction Improved by New Biomarkers

CRISPR-Engineered Cells Release Drug in Response to Inflammation When Implanted into Mice
Drug Discovery

CRISPR-Engineered Cells Release Drug in Response to Inflammation When Implanted into Mice

Self-Injecting Pill Could Allow Oral Delivery of Monoclonal Antibody and Other Protein Drugs
Drug Discovery

Self-Injecting Pill Could Allow Oral Delivery of Monoclonal Antibody and Other Protein Drugs

123...33Page 2 of 33
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.